Marshall Wace LLP Increases Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Marshall Wace LLP boosted its position in shares of Teleflex Incorporated (NYSE:TFX) by 8.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 55,087 shares of the medical technology company’s stock after purchasing an additional 4,284 shares during the period. Marshall Wace LLP owned approximately 0.12% of Teleflex worth $9,804,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Hengehold Capital Management LLC raised its holdings in Teleflex by 7.3% during the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock worth $229,000 after purchasing an additional 88 shares in the last quarter. Exchange Traded Concepts LLC grew its position in shares of Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after buying an additional 94 shares during the last quarter. Isthmus Partners LLC raised its stake in Teleflex by 7.3% during the 4th quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company’s stock worth $273,000 after acquiring an additional 105 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in Teleflex by 2.4% in the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company’s stock valued at $888,000 after acquiring an additional 118 shares during the last quarter. Finally, QRG Capital Management Inc. boosted its stake in Teleflex by 5.8% in the fourth quarter. QRG Capital Management Inc. now owns 2,178 shares of the medical technology company’s stock valued at $388,000 after acquiring an additional 119 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

TFX has been the subject of a number of research analyst reports. Mizuho set a $155.00 target price on Teleflex in a research report on Wednesday, April 16th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Wednesday, March 12th. Bank of America cut shares of Teleflex from a “neutral” rating to an “underperform” rating and decreased their price target for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. Raymond James cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Finally, Piper Sandler restated a “neutral” rating and issued a $140.00 price target (down previously from $255.00) on shares of Teleflex in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $169.63.

Teleflex Stock Performance

Shares of TFX stock opened at $129.33 on Tuesday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12-month low of $124.66 and a 12-month high of $249.91. The company has a market cap of $6.00 billion, a price-to-earnings ratio of 25.71, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19. The stock has a 50 day simple moving average of $142.90 and a 200-day simple moving average of $176.30.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. On average, equities analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 1.05%. Teleflex’s dividend payout ratio (DPR) is presently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.